Our community has come together, like many others, to combat the opioid crisis. Several local agencies have rallied to create impactful community resources. A 2016 survey by Castlight, which listed Wilmington, NC as the #1 city for opioid abuse in the United States, was a wake-up call to the level of severity this community has been affected by opioid-related fatalities and hardships. At Alcami, we work with our clients to develop abuse deterrence medicines to help combat this nationwide epidemic that hits home, even here in Wilmington.
Ready to Get Started?
MORE CONTENT ON THIS TOPIC
- Considerations for Abuse-Deterrent Category One Syringeability Studies
- Alcami Donation to Outfit TROSA Medical Department
- Editorial: Tackling the Opioid Crisis with Abuse-Deterrent Formulations
- Alcami Helps Fight Opioid Addiction Epidemic
- ON-DEMAND WEBINAR: Abuse-Deterrent Category One Testing: Syringeability Studies
- Abuse-Deterrent Studies – An Interview with Angela Moore
- Executive Brief: An Opioid Abuse-Deterrent Roadmap for the Pharmaceutical Industry
- White Paper: Abuse-Deterrent Studies for Controlled Drugs - A Changing Landscape
- ON-DEMAND WEBINAR: Demonstrate Abuse-Deterrent Properties in Opioid Formulations